what is known already: The rapid increase in the prevalence of cryptorchidism suggests that environmental factors, such as endocrine disruptors, may be involved. OTCs are endocrine disruptors at very low concentrations due to activation of the retinoid X receptor (RXR). study design, size, duration: Between the years 1997 and 2001, placentas from mothers of cryptorchid boys and from healthy controls were collected from Denmark (39 cases, 129 controls) and Finland (56 cases, 56 controls). In Denmark 33 and 6 boys, and in Finland 22 and 34 boys had mild or severe cryptorchidism, respectively. The association between concentrations of four OTCs [monobutyltin (MBT), dibutyltin (DBT), tributyltin (TBT) and triphenyltin (TPhT)] and case-control status was estimated.
Introduction
Organotin compounds (OTCs) are a large class of compounds with widely varying properties, and they have been used for many different purposes. Trisubstituted OTCs, tributyltin (TBT) and triphenyltin (TPhT) have strong biocidal activity toward aquatic organisms and their use in antifouling paints in boats and ships has polluted waters, sediments and aquatic biota in many areas. TBT and TPhT are highly toxic to many aquatic species, and the most sensitive toxic effect, imposex, i.e. the superimposition of male characteristics, such as penis and a vas deferens, onto females, occurs in some molluscs at TBT concentrations in water as low as 1 ng/l (Hoch, 2001) . The antifouling use of OTCs was banned in all vessels in EU in (European Union, 2003a . TPhT was also used as pesticide, but it has been banned in Europe since 2002 due to operator safety concerns and its possible impact on non-target organisms (European Union, 2002a,b) . A scientific panel of the European Food Safety Authority (EFSA) has established a group tolerable daily intake of 250 ng/kg body weight for the sum of dibutyltin (DBT), TBT, TPhT and dioctyltin based on the immunotoxicity of these compounds (EFSA, 2004) . As for humans, there is strong evidence that fish is the main source of OTCs, especially of TBT and TPhT, based on the analysis of food group composite samples (Toyoda et al., 2000; Rantakokko et al., 2006) . Known or suspected risk factors for cryptorchidism, the maldescent of testis, include genetic susceptibility, preterm birth, low birthweight and being small for gestational age, other genital abnormalities, maternal gestational smoking and alcohol consumption, gestational diabetes and environmental contaminants (Barthold, 2008; . The prevalence of cryptorchidism in newborn boys appears to have increased in some areas such as Great Britain and Denmark over the past decades, and its current prevalence is considerably higher in Denmark than in Finland (Boisen et al., 2004) . Although the reason for this is as yet unknown, the rapid increase in prevalence suggests that environmental factors are involved Sharpe, 2006) . In our previous studies, we have found that the sum concentration of the most abundant persistent pesticides and polybrominated diphenylethers in breast milk was significantly higher in boys with cryptorchidism than in controls Main et al., 2007) . Furthermore, we have found that levels of several pesticides, dioxins and PCBs are significantly higher in Denmark than in Finland (Shen et al., 2008; Krysiak-Baltyn et al., 2010) . Cryptorchidism, hypospadias, impaired semen quality and testicular cancer are all elements of the so-called testicular dysgenesis syndrome . Recent data show that semen quality of young men has declined in both countries, although it seems that the decline has occurred later in Finland than in Denmark (Jorgensen et al., 2002 (Jorgensen et al., , 2011 .
OTCs have known endocrine-disrupting potential, and in animal experiments effects on male sexual development have been observed. In a two-generation reproductive toxicity study with 5-125 ppm dietary TBT with male rats, the weights of the testis and epididymis were decreased and homogenization-resistant spermatid and sperm counts were reduced. TBT had no effect on testis descent in F1 and F2 generations. At higher doses of TBT serum 17b-estradiol was decreased in F1 and F2, whereas there was a dose-dependent increase in serum testosterone in F1 and lutenizing hormone (LH) in F2. These hormonal changes corresponded to those caused by aromatase inhibition (Omura et al., 2001) . Administration of 0.5 -15 mg TBT/kg bw or 2-12 mg TPhT/kg bw to pubertal male rats resulted in a delay in the completion of preputial separation and changes in weights of one or more reproductive organs. Contrary to results of Omura, high doses of TBT and TPhT significantly decreased the serum concentrations of testosterone, while a high dose of TPhT significantly increased LH levels (Grote et al., 2004) . In rats delayed testicular descent has been observed after in utero exposure to 2-6 mg/kg bw of TPhT, but this occurred together with the delay of other developmental landmarks such as fur development, tooth eruption and eye opening (Grote et al., 2007) .
There has been some controversy regarding the critical target molecule for endocrine disruption by OTCs. It has been shown that TBT is an inhibitor of human placenta cytochrome P450 aromatase at low micromolar concentrations (Heidrich et al., 2001 ) by competitive inhibition (Cooke, 2002) . Also, 4-10 mM TBT in binary combinations with bisphenol-A, nonylphonol or chlordecone showed synergistic inhibitory effects on aromatase activity (Benachour et al., 2007) . Contrary to these observations, in studies with human placental choriocarcinoma cells, TBT and TPhT in the non-toxic low nanomolar concentration range caused an increase in aromatase activity. Also, these OTCs increased mRNA expression and secretion of human chorionic gonadotrophin. As a possible mechanism, OTCs were shown to be retinoid X receptor (RXR) agonists (Nakanishi et al., 2002 . Interestingly, in two populations of gastropods, one with 37% and another with 100% imposex, there was no difference in aromatase activity, suggesting mechanisms other than aromatase inhibition (Morcillo and Porte, 1999) . More recently, convincing evidence has been provided that TBT activates the human nuclear receptor RXR-a-PPAR-g heterodimer through its interaction with RXR-a, where a covalent bond forms with the Sn-atom and residue Cys 432 of Helix H11. In addition to RXR-a, also RXR-b and RXR-g are activated (le Maire et al., 2009) . TBT binds to RXRs and activates signalling across phyla from gastropods to mammals (Nishikawa et al., 2004; Iguchi and Katsu, 2008 ) and has very recently been shown to be tissue specifically involved in the development of imposex in gastropods (Lima et al., 2011) .
Therefore, this study aimed at evaluating the possible impact of antenatal exposure to OTCs [monobutyltin (MBT), DBT, TBT, TPhT], as assessed by placenta measurements, on testicular descent at birth and reproductive hormone levels at 3 months of age. To our knowledge this type of study has not been performed before.
Materials and Methods
The study was conducted according to the Helsinki II declaration after informed oral and written consent of the parents. The ethical committees (Finland: 7/1996 , 6/2001 ) and the Danish Data Protection Agency (1997-1200-074) approved the study.
Study population
Placentas samples were obtained from a joint prospective, longitudinal cohort study performed 1997 -2001 at the Turku University Hospital, Turku, Finland, and the National University Hospital (Rigshospitalet, Hvidovre Hospital) Copenhagen, Denmark. This bi-national study aimed at establishing contemporary prevalence rates for cryptorchidism and hypospadias, and at evaluating risk factors and other background variables by means of a questionnaire and biological samples (blood, placentas and breast milk).
Questionnaire on fish consumption
The questionnaire contained three questions on the frequency of maternal fish eating. The questions asked were: How often do you eat fish (not shell fish) as the main course, on bread or in salads 1 ¼ several times each week; 2 ¼ several times each month; 3 ¼ less than once a month; 4 ¼ never. This question was included in the Finnish study from the beginning, and 1 year after the start of the study in the Danish study. In Denmark, 33% of control and 26% of case mothers did not provide information on fish consumption questionnaire, as opposed to 8% of Finnish case mothers and 0% of Finnish controls.
Study setup and clinical examination
Exposure measurements were prospectively planned to include persistent and non-persistent chemicals in breast milk and placenta (EU grant QLK4-CT-2001-00269), most of which have been previously reported (Shen et al., 2005 (Shen et al., , 2007 (Shen et al., , 2008 Damgaard et al., 2006; Main et al., 2006a Main et al., , 2007 Krysiak-Baltyn et al., 2010; Krysiak-Baltyn et al., 2012; Virtanen et al., 2012) . At a later stage, also OTCs were included in the project (Academy of Finland grant, 20525) as data from animal experiments suggested that they might be potentially hormone disrupting in humans. Recruitment strategy, inclusion criteria and clinical examination of the children, i.e. the identification of cryptorchidism, have been previously described (Boisen et al., 2004; Main et al., 2006b; Suomi et al., 2006) and were strictly standardized. Boys with normally descended testis, including retractile testes, were used as controls in this study under the terms controls or healthy boys. Boys with undescended testes (nonpalpable, inguinal, suprascrotal, high scrotal), either uni-or bilaterally at birth, were included in the group of cryptorchid boys. All boys were examined at birth, at 3 and 18 months of age and examiners were blinded to the results of chemical analyses. Preterm boys were diagnosed as cryptorchid if they had an undescended testis when examined around the expected date of delivery. Birthweight and length were obtained from hospital records. The supine length of the children was measured with infantometers (in Denmark: Kidimeter, Raven Equipment Ltd., United Kingdom; in Finland: Pedihealth Ky, Oulu, Finland). Weight was measured on a digital scale (Solotop Oy, Baby scale model, Helsinki, Finland). Weight for gestational age was calculated using national standards as % deviation from the expected mean (Pihkala et al., 1989; Marsal et al., 1996) , 222% being equivalent to -2 standard deviations.
Placenta samples
In Denmark, placenta samples were collected from all participants (casecohort design). In Finland, due to lack of storage space, placenta samples were collected from boys with cryptorchidism at birth and matched controls [matching criteria: parity, maternal smoking (yes/no), diabetes (yes/no), gestational age (+7 days) and date of birth (+14 days)] as a nested case -control design. Whole placentas were collected by the midwives and frozen immediately in two layers of polyethylene bags (2208C). Placentas were not bled prior to storage and were weighed fresh.
A total of 280 placentas (168 Danish/ 112 Finnish) were selected for OTC measurements. Birth examination data were used for classification of cryptorchid and healthy boys. In Finland, 56 case-control pairs for whom both placentas were available were selected for chemical analyses. In Denmark, all available placentas from cryptorchid boys were chosen (n ¼ 39). Control placentas were selected randomly from the total Danish cohort (n ¼ 129).
Analysis of OTCs from placentas
The chemical analysis of OTCs was carried out in the Chemical Exposure Unit of the National Institute for Health and Welfare, which is an accredited testing laboratory (Finnish Accreditation Service, code T077, EN ISO/IEC 17025). Placentas were defrosted, and the umbilical cord and all readily removable membranes were discarded. Whole placentas were homogenized in a mixer (Büchi Mixer B-400, Büchi Laboratories AG, Flawil, Switzerland) and 10 g of the homogenate was lyophilized. Dried homogenate was pulverized in a mortar and 0.25 g of it was taken for analysis. The compounds analysed were MBT, DBT, TBT and TPhT. Individual, pure model OT compounds were bought either from DrEhrenstorfer (Augsburg, Germany) or from Acros (Geel, Belgium). Perdeuterated analogues of MBT, DBT, TBT and TPhT were used as internal standards for the respective native compounds purchased from the Swiss Federal Institute for Environmental Science and Technology (Dubendorf, Switzerland) (Arnold et al., 1998) .
To 0.25 g of dried placenta in a 12 ml screw capped test tube, 1.0 g of NaCl (Merck, Darmstadt, Germany) was added and the solids were mixed. Then 100 ml of internal standard solution in methanol (Merck), 3 ml of 25% tetramethyl ammonium hydroxide (Merck, Hohenbrunn, Germany) and 5 ml of methanol were added and samples were vortexed for 15 min at 2500 rpm. Samples were centrifuged for 1 min at 2000 rpm and the top extract was poured to another 12 ml screw capped test tube to which 1.2 ml of acetic acid (J.T. Baker, Deventer, The Netherlands) and 1.5 ml of 5 mol/l sodium acetate-acetic acid buffer (pH 4.5) were added. To form volatile derivatives of OTCs 1.0 ml of 2% sodiumtetraethylborate (Acros, Geel, Belgium) in methanol was added and samples were kept at room temperature protected from light for 60 min. Then 2 ml of hexane (Merck) was added, samples were mixed in a carousel extractor at 30 rpm for 5 min and centrifuged at 2000 rpm for 2 min to transfer ethylated OTCs to the hexane phase. The hexane phase was pipetted to 60 8 mm glass columns containing from bottom to top 1.5 cm of basic activated alumina (Merck) and 1.0 cm of sodium sulphate (Merck). OTCs were eluted from the column with 9 ml of 6% diethylether-hexane and concentrated very carefully to 30 -50 ml of hexane in a conical autosampler vial. Finally, 10 ml of tetrabutyltin solution was added to autosampler vials as a recovery standard.
Gas chromatography/mass spectrometry analysis was performed using an Agilent 6890 gas chromatograph (Agilent Technologies, Little Falls, DE, USA) connected to a Waters Autospec Ultima high-resolution mass spectrometer (Waters, Manchester, GB) operated in the selected ionmonitoring mode. The two most intensive fragment ions of each ethylated OTC were monitored. The column used was a DB-1 (Agilent Technologies, Folsom, CA, USA) capillary column (12 m, 0.20 mm I.D., 0.33 mm film).
Two blank samples in each samples series were analysed as real samples. The blank result was subtracted from placenta results. Limits of quantification (LOQs) were 0.1 ng/g fresh weight (fw) for MBT and DBT, and 0.02 ng/g fw for TBT and TPhT. An inhouse made placenta sample was analysed as a quality control sample in each series (n ¼ 12) of samples. Average concentrations and coefficients of variation (CV) of control placenta were 0.11 ng/g fw and 12.1% for MBT, 0.30 ng/g fw and 13.1% for DBT, 1.13 ng/g and 15.2% for TBT and 0.04 ng/g fw and 12.7% for TPhT.
Blood samples and hormone analysis
Sampling of venous non-fasting blood samples (4 ml) from the infants took place at the 3 months' examination. Overall, a blood sample was successfully obtained from 69% of the study participants. For 31% of infants no blood sample was obtained due to parental refusal or technical problems in the sampling. After clotting, the blood samples were centrifuged, the sera were separated and stored at 2208C. Serum samples were analysed as duplicates for reproductive hormones at one laboratory and the technician was blinded to the samples (Rigshospitalet, Denmark). Each batch of samples contained samples from both countries of both cryptorchid and healthy boys (up to 160 samples per analysis) to minimize any inter-assay variation effect.
Time-resolved immunofluorometric assays (Delfia w , Wallac, Inc., Turku, Finland) were used to analyse serum follicle-stimulating hormone (FSH), luteinizing hormone (LH) and sex-hormone binding globulin (SHBG). Detection limits were 0.06 IU/l for FSH, 0.05 IU/l for LH and 0.23 nmol/l for SHBG. The intra-and inter-assay CV were ,5% in both gonadotrophin assays and ,6% for SHBG. Serum testosterone was measured with radioimmunoassay (Coat-a-Count w , Diagnostic Products Corp., Los Angeles, CA). The method had a detection limit of 0.23 nmol/l and intra-and inter-assay CVs were less than 10%. Free testosterone index was calculated with the equation: testosterone × 100/ SHBG. A double antibody enzyme-immunometric assay was used for the analysis of serum inhibin B (Main et al., 2006a) . The detection limit was 20 pg/ml, and intra-and inter-assay CVs were ,15 and ,18%, respectively. Total serum estradiol was measured by radioimmunoassay (Pantex Corp.; Immunodiagnostic Systems Limited, Santa Monica, CA) (Chellakooty et al., 2003) . The intra-assay CV was less than 7.5% and the inter-assay CV less than 13%. Ratios between hormones were calculated by simple division: LH/testosterone, LH/free testosterone, FSH/ inhibin B and testosterone/estradiol ratio.
Statistics
Population characteristics are given as medians and percentiles (2.5th, 97.5th). Differences in the background variables between boys with/ without cryptorchidism and between Danish/Finnish populations were analysed by Mann-Whitney U-test, x 2 test and Fisher's exact test.
Differences in the placenta OTC concentrations between countries and between boys with/without cryptorchidism were also tested by MannWhitney U-test.
OTC results ,LOQ were assigned the value LOQ/2 in all analyses using absolute measurements.
Two pairwise non-parametric Spearman rank correlation tests between the concentrations of selected OTCs by country were performed (DBT versus TBT and TBT versus TPhT). The first test was done only for those samples where the concentrations of both OTCs in the pair were .LOQ. In the second test, concentrations ,LOQ were treated as LOQ/2. Mann-Whitney U-test was used to study the difference in the TBT/DBT ratios between the countries as this may reflect the difference in the sources of OTCs. Also in this case the first test was done only for those samples where both OTCs in the pair were .LOQ and in the second test concentrations ,LOQ were treated as LOQ/2.
Correlations between TBT concentration and the date of childbirth by country was also tested by Spearman rank correlation. The date of birth for the first child in the cohort was set at zero, the date of birth for all consecutive children was then calculated as numbers of days elapsed since the first child. This variable was applied to control for any time trends in TBT concentration in both countries in the study period from 1997 to 2001. Only TBT results .LOQ were used in this test.
The relationship between fish consumption and concentration of TBT, sum concentration of butyltins and sum concentration of all OTCs were studied by multinomial logistic regression by country. The concentrations ,LOQ were calculated as LOQ/2. Frequencies of eating fish in hot meals, fish on bread and in fish salad were compared separately.
For Danish data, logistic regression adjusted for mothers' age at birth, pre-pregnancy BMI, parity, gestational age, family history of cryptorchidism and alcohol consumption was used to study the relationship between OTC concentration and cryptorchidism. As diabetes is a known risk factor for cryptorchidism, a separate analysis excluding diabetic study subjects was also performed. Adjustment for family history of cryptorchidism has the potential for over-adjustment as cryptorchidism in the father or brother may be due to shared environmental exposures such as those in focus. A separate analysis excluding it from the list of covariates was also performed. In addition, also unadjusted logistic regression analysis was done. To do these tests, OTC data were classified into two or three categories depending on the distributions of concentrations of specific OTC. As the reference groups, samples with OTC concentrations ,LOQ were selected. Reference groups were thus ,0.1 ng/g fw for DBT, ,0.02 ng/g fw for TBT and TPhT and ,0.12 ng/g fw for the sum of OTCs (when calculating the sum, concentrations less than the LOQ were replaced by LOQ/2). For DBT, TBT and sum of OTCs, three categories were used to study the stability of the associations across different concentration ranges.
For Finnish data, conditional logistic regression adjusted for mothers' age at birth, pre-pregnancy BMI, family history of cryptorchidism and alcohol consumption was used to study the relationship between OTC concentration and cryptorchidism. As for Danish data, an unadjusted analysis, an analysis without adjustment for the family history of cryptorchidism, and a separate analysis without diabetic subjects were also done. Exposure data were also classified into two or three categories. The limits of the tertile categories were higher in Finnish than in Danish subjects for TBT and the sum of OTCs because only in 1% of Finnish samples was the TBT concentration below LOQ, whereas the TBT concentration was below LOQ in 63% of Danish samples.
For Finnish data only, association with cryptorchidism was also studied with continuous TBT concentrations. Normality of TBT concentrations was first tested by one sample Kolmogorov-Smirnov test. Conditional logistic regression of log-transformed TBT concentrations adjusted for mothers' age at birth, pre-pregnancy body mass index (BMI, kg/m 2 ), alcohol consumption and family history of cryptorchidism was performed. Also an unadjusted analysis and an analysis without diabetic subjects were performed.
Univariate analysis of variance weighted for sampling fractions of cases (121/55 for Finnish and 94/39 for Danish, respectively) and controls (5677/55 for Finnish and 952/129 for Danish, respectively) from the total cohort (Richardson et al., 2007) was used to assess the correlation between serum levels of reproductive hormones (log-transformed LH, FSH, SHBG, inhibin B, square root-transformed serum testosterone and free testosterone index and log-transformed ratios of hormones) and dichotomised OTC concentrations in placentas by country. Also medians and percentiles (2.5th, 97.5th) of hormone levels in each OTC category were calculated. For Finnish samples, one case -control pair was dropped out from the weighted univariate analysis of variance because it did not belong to the original Finnish cohort collected during the years 1997-1999, but was collected in the year 2000 for the casecontrol study on risk factors of cryptorchidism. Weighting for sampling fractions in the univariate analysis of variance requires all samples to be collected from the same cohort. In addition, bivariate Spearman rank correlations were calculated for the hormone levels of Finnish infants against continuous placental TBT concentrations.
All statistical tests, including regression analyses, were performed with PASW Statistics 18.
Results

Background characteristics
Most of the mother's and boy's background characteristics have been reported previously Virtanen et al., 2012) . The data, with the addition of family history of cryptorchidism, maternal alcohol consumption, binge drinking and fish consumption, are summarized in Table I . As for the maternal age, family history of cryptorchidism, selfreported smoking, alcohol consumption, binge drinking and parity, there were no significant differences between cryptorchid and control boys. Gestational age and birthweight were slightly lower in Danish cryptorchid boys than controls, but there was no difference among Finnish boys. Diabetes was more prevalent in Finnish mothers of cryptorchid boys than in their controls, as we could not always find enough controls matched by this criterion. There was no difference in diabetes status among Danish mothers. During the study period, the date of childbirth did not differ significantly between cryptorchid boys and controls in either country (P ¼ 0.33 Denmark/P ¼ 0.95 Finland) (data not shown). Danish mothers were a little older than Finnish (median 30.6 years (2.5th -97.5th percentiles 23.6 -38.8) versus 28.7 years (21.4-39.7), P , 0.011), had a lower parity (P , 0.033), consumed more alcohol (P , 0.001) and smoked more often (P , 0.04). More Finnish mothers had diabetes mellitus (P , 0.004), but pre-pregnancy BMI (P ¼ 0.23) and family history of cryptorchidism (P ¼ 0.26) did not differ significantly between the countries.
There was no significant difference in the frequency of eating fish between mothers of cryptorchid and control boys in either country (Table I) . Combining cases and controls in each country, the frequency of eating fish in hot meals was significantly higher (P ¼ 0.004) in Finland, whereas the frequencies of eating fish on bread (P , 0.001) and fish in salad (P ¼ 0.007) were significantly higher in Denmark.
Concentrations of OTCs in placentas
Generally, the concentrations of the four OTCs were low, less than the LOQ in a large proportion of samples. This was especially true for MBT, for which 82-96% of the results were ,LOQ depending on the country and group (Table II) . Taking together both controls and cases, OTC concentrations were significantly higher in Finland than in Denmark for DBT (P , 0.001), TBT (P , 0.001) and TPhT (P ¼ 0.003), but not for MBT (P ¼ 0.84) (data not shown). The difference was largest for TBT, for which the mean concentration in Finnish placentas (1% of samples ,LOQ) was 7.2 times higher than in Denmark (63% of samples ,LOQ).
Correlations and ratios between different OTC
In the first test with concentrations .LOQ, the correlation between DBT and TBT in Finnish placentas was significant (n ¼ 74, R ¼ 0.88, P , 0.001), but not the correlation between TBT and TPhT (n ¼ 47, R ¼ 0.09, P ¼ 0.55). In Danish placentas, no significant correlations between DBT and TBT (n ¼ 30, R ¼ 0.00, P ¼ 1.00) or between TBT and TPhT (n ¼ 24, R ¼ 20.24, P ¼ 0.27) were found. There was little relevant change to these results in the second test with values below the LOQ replaced by LOQ/2. No significant correlations between MBT and other OTCs were observed.
In the first Mann-Whitney U-test with concentrations of DBT and TBT .LOQ, the TBT/DBT concentration ratio in Finnish placentas (median ¼ 2.08) was significantly higher (P , 0.001) than in Danish placentas (median 1.08). There was little relevant change to these results in the second test with values below the LOQ replaced by LOQ/2.
Date of birth and placenta TBT concentrations
There was no significant correlation between the date of birth and TBT concentration for either Finnish (n ¼ 111, R ¼ 20.09, P ¼ 0.33) or Danish (n ¼ 63, R ¼ 20.16, P ¼ 0.22) placentas, i.e. no time trend was observed in either country.
Organotin compounds and cryptorchidism
Fish consumption and OTC concentrations
None of the reported fish consumption frequencies were significantly correlated with the concentration of TBT, the sum concentration of butyltins or the sum concentration of all measured OTCs in placentas (data not shown).
OTCs in placenta and cryptorchidism
In Danish case placentas, the median concentration of DBT was significantly higher than in controls, whereas in Finnish case placentas the concentrations of DBT and TBT were significantly lower than in controls (Table II) . In the logistic regression analysis, the results differed between the countries (Table III) . For Danish mother-child pairs, there was a significant positive association between placenta DBT concentration and cryptorchidism when comparing both the second and third categories to the first category. For other OTCs and the sum of OTCs, the associations were less consistent. On the contrary, for Finnish motherchild pairs, there was a significant negative association between placenta TBT concentration and cryptorchidism when comparing the third category to the first category. Also here the associations were less consistent for other OTCs, and especially for DBT the results varied a lot depending on the category limits (see footnote 'e' of Table III) . Except for DBT in Finnish placentas, there were no major changes in the unadjusted analysis. Analyses without adjustment for family history of cryptorchidism or exclusion of diabetic subjects from fully adjusted analysis did not materially change the results (data not shown).
The distribution of TBT concentrations in Finnish placentas was not normal (P ¼ 0.001), but it was after log-transformation (P ¼ 0.50). There was a statistically significant negative association between the log-transformed TBT concentration and cryptorchidism (OR ¼ 0.12, 95% CI 0.03 -0.46). There was little change in the unadjusted analysis or by exclusion of diabetic subjects. BMI, maternal pre-pregnancy BMI; WGA, weight for gestational age was calculated using national standards as percent deviation from the expected mean (Marsal et al., 1996; Pihkala et al., 1989) , 222% being equivalent to 22SDs; prematurity ≤259 days of gestation; SGA, small for gestational age. 
OTCs in placenta and reproductive hormones
Associations between infant serum reproductive hormone levels and categorized placenta OTCs concentrations are presented in Table IV . LH was significantly lower in the upper category of DBT (P ¼ 0.035), TBT (P ¼ 0.021) and OTCs sum (P ¼ 0.008) of the Finnish placentas. Testosterone was significantly lower in the upper category of OTC sum (P ¼ 0.044) of the Danish placentas. Also the LH:testosterone ratio was slightly higher in the upper categories of TBT (P ¼ 0.078) and OTCs sum (P ¼ 0.064), and the testosterone:estradiol ratio was significantly lower in the upper categories of TBT (P ¼ 0.014) and OTCs sum (P ¼ 0.005) of the Danish placentas. Inhibin B was significantly higher in the upper category of TBT (P ¼ 0.008) and slightly higher in the upper category of OTC sum (P ¼ 0.060) of the Finnish placentas. Similarly, the FSH:inhibin B ratio was significantly lower in the upper category of TBT (P ¼ 0.029) and slightly lower in the upper category of OTC sum (P ¼ 0.061) of the Finnish placentas. As in the categorized analysis, LH had significant negative correlation (R ¼ 20.29, P ¼ 0.004) and inhibin B significant positive correlation (R ¼ 0.23, P ¼ 0.030) with continuous TBT concentration in the Finnish placentas.
No other significant correlations with hormones or hormone ratios were found.
Discussion
This is to our knowledge the first study on the potential relationship between congenital cryptorchidism in humans and prenatal exposure to OTCs, as assessed by the measurement of the OTC concentration in whole placenta homogenates. Statistically significant associations of placenta OTC concentrations with cryptorchidism status and infant reproductive hormone levels were found in the Finnish and Danish mother-child pairs. There was a negative association of TBT and DBT (third tertile) levels in Finnish placentas with cryptorchidism. TBT, DBT and the sum of OTCs had negative associations with serum LH, and/or positive association with serum inhibin B in Finnish infants. On the contrary, in Danish placentas DBT levels were positively associated with cryptorchidism. The sum of OTCs showed a negative association with infant serum testosterone in the Danish material.
Whether OTC levels in placental tissue reflect exposure in a time window that is likely to be relevant for cryptorchidism occurrence is Organotin compounds and cryptorchidism a very important thing to consider. Unfortunately, there are no systematic studies on human tissue distribution of OTCs even though they have been found in human blood (Kannan et al., 1999; Rantakokko et al., 2008) , serum (Lo et al., 2003) and liver (Kannan and Falandysz, 1997; Takahashi et al., 1999; Nielsen and Strand, 2002) . There is an extensive study with Sprague-Dawley rats on the organotin speciation and tissue distribution in dams, fetuses and neonates following oral administration of TBT. On gestational day (GD) 20 in the highest exposure group (10 mg/kg bw/d), the concentrations of TBT and DBT were the highest in dams' brain, liver and spleen (1500-1800 ng/g and 400-1900 ng/g), but were also high in the placenta (650 ng/g and 300 ng/g). On GD20, levels of TBT and DBT in placenta were 5-fold higher than the levels in maternal blood and 10-fold higher than in milk on post-natal day 6. At GD20, the liver and brain of fetuses contained TBT and DBT at levels that were approximately half of the equivalent tissues in the dams (Cooke et al., 2008) . Also in a systematic review of OTCs toxicokinetics, the basic results for tissue distribution were very similar, but placental transfer was not treated (Appel, 2004) . Only one study on human elimination exists. After oral ingestion of TBT by a volunteer, 5% of the dose was found in the urine mainly as DBT. Metabolites in the urine decreased rapidly during the first days after administration (Uhl, 1986; Appel, 2004) . Regarding the time window, testicular descent has been described to occur in two phases (Hutson, 1985) . The first transabdominal phase occurs in humans by 15th week of gestation (Hutson et al., 1997) , and according to animal studies it is dependent on the action of insulin-like peptide 3 (Insl3) (Nef and Parada, 1999; Zimmermann et al., 1999) . This phase is rarely disrupted in humans (Cendron et al., 1993) . In the latter inguinoscrotal phase, the testis and the epididymis pass the inguinal canal and migrate from the inguinal area into the scrotum and the gubernaculum shrinks (Heyns, 1987; Barteczko and Jacob, 2000; Amann and Veeramachaneni, 2007) . This phase starts around 23rd week of gestation in humans and by the 35th week of gestation, the testes have usually descended (Heyns, 1987; Sampaio and Favorito, 1998; Rotondi et al., 2001) . The inguinoscrotal phase is dependent on androgens (Hutson, 1986) , and according to animal studies proper androgen action must occur already before Adjusted for parity, gestational age, mother's age at birth, mother's pre-pregnancy BMI, family history of cryptorchidism and alcohol consumption. Case -cohort design.
b Adjusted for mother's age at birth, mother's pre-pregnancy BMI, family history of cryptorchidism and alcohol consumption. Nested case -control design [matching criteria: parity, maternal smoking (yes/no), diabetes (yes/no), gestational age (+7 days) and date of birth (+14 days)].
c Difference between cryptorchid boys and controls in logistic regression analysis. In the calculation of the sum of OTCs concentrations less than the LOQ were calculated as LOQ/2. As LOQs were 0.1 ng/g fw for MBT and DBT, and 0.02 ng/g fw for TBT and TPhT, in the Sum of OTCs category ,0.12 ng/g fw of Danish data concentrations of all OTCs were ,LOQ. In the second category the model was unstable due to small number of samples and covariates had substantial effect on the OR depending on the setting of the upper limit of this category. If category limit had been 0.19 ng/g fw instead of 0.14 ng/g fw, OR and 95% CIs would have been almost the same as in the unadjusted analysis. Organotin compounds and cryptorchidism this phase rather than during it (Spencer et al., 1991; Amann and Veeramachaneni, 2007) . Animal studies suggest that Insl3/ its receptor signaling may also have a role in this phase (Yuan et al., 2010; Bay and Andersson, 2011; Kaftanovskaya et al., 2011) . Taken together, according to animal studies placental levels should reflect fetal exposure levels. However, OTCs may be rather quickly eliminated also from the placenta, which makes the exposure assessment less accurate if the intake of OTCs varies a lot during pregnancy.
Except for MBT, concentrations of OTCs were significantly higher in Finnish than in Danish placentas. The difference was especially striking for TBT, the mean concentration of which was 7 times higher in Finland. Of the background variables given in Table I , fish consumption can only partly explain this difference. The frequency of eating fish in hot meals was slightly, but significantly higher in Finland but the frequency of fish consumption on bread and in salads was higher in Denmark. However, except for TBT in Finland and to some extent DBT in Denmark and Finland, the large number of samples ,LOQ diminishes the biological significance of these results. In particular, for MBT, the results are questionable due to the very high number of samples ,LOQ. Regarding the difference in TBT concentration between Finnish cases and control, the measurement of OTCs was not considered when the study was planned, and we can see no selection bias that could have even inadvertently favoured controls to have higher TBT concentrations in Finland. To understand these results, the potential contamination of fish consumed, other possible sources of OTCs, and correlations and ratios of OTCs measured in placentas in both countries need to be considered.
Seafood is considered to be the main dietary source of OTCs (Kannan et al., 1995; Toyoda et al., 2000; Guerin et al., 2007) , although food to plastic contacts may also represent a notable exposure route for humans (Sadiki and Williams, 1999; Takahashi et al., 1999; Azenha and Vasconcelos, 2002) . In the Finnish market basket study, the intake of TBT was twice that of DBT, and seafood was the sole source of TBT and TPhT (Rantakokko et al., 2006) . Of the fish-derived OTC intake in Finland, 61% comes from wild indigenous fish . Finnish placenta samples were collected in the Turku University Hospital. Fish in the Baltic Sea area next to Turku are heavily contaminated by OTCs with TBT concentrations typically 10-30 times higher than DBT . During the placenta sample collection, fish consumption was around 40 g/day in Finland (National FINDIET 2007 Survey, Finnish Game and Fisheries Research Institute), which is similar to women's fish consumption in Copenhagen in the 1990's, 37 g/day. Fish species that contributed most to the fish intake in Denmark were herring, mackerel, salmon and cod (Welch et al., 2002) . In a European-wide study the levels of TBT in these fish species were at least 3-10 times higher than those of DBT (European Union, 2003b) . The profiles of fish-derived OTCs are thus likely to be similar in both countries with a dominating TBT component. However, in this study there was no correlation between DBT and TBT in Danish placentas, whereas a strong correlation was observed in Finnish placentas. In addition, the TBT/DBT concentration ratio was significantly higher in Finnish than in Danish placentas. It is thus likely that the majority of OTC intake in Finland is derived from fish and that the higher TBT contamination in Finnish placentas is due to the quality rather than the quantity of fish consumed. In Denmark, other sources than fish probably contribute to the OTC intake and to the observed difference in TBT-DBT correlation and concentration ratio. As an example, elevated concentrations of DBT and MBT have been found in some plastic products, such as baking parchments made from siliconized paper. Cooking tests indicated the transfer of BTs from baking parchments to foodstuffs (Takahashi et al., 1999) .
Because of the different distributions of exposure, the results between Denmark and Finland are not easy to compare for TBT for which country-specific exposure tertiles had to be used. Two potential interpretations can be found for the opposite associations between placental DBT and TBT concentrations in Finland and Denmark and cryptorchidism.
First, differences in absolute exposure burden may cause opposite health effects. For example, TBT had an inverted U-shaped proliferation response on peripheral blood mononuclear cells (PBMCs) in pup seals (Frouin et al., 2008) , i.e. the dose-response of OTCs can be nonmonotonous. In vivo non-monotonous effects have been observed with TBT in relation to body fat deposition. TBT augments adipogenesis via the interaction with PPARg/RXRa when exposure occurs during fetal development . This effect likely occurs through the sensitization of multipotent stromal stem cells to differentiate into adipocytes (Kirchner et al., 2010) . Estrogens regulate fat mass by increasing lipolysis through modulation of the expression of genes that regulate adipose deposition and differentiation and adipocyte metabolism (Cooke and Naaz, 2004, Pallottini et al., 2008) . This regulation mainly occurs via estrogen receptors (ERa and ERb) which also mediate the action of several environmental chemicals (e.g. pesticides, organophosphates, polychlorinated biphenyls and phthalates) (Penza et al., 2011) . In salmonids TBT increased body mass and altered several physiological parameters at doses between 0.4 and 3.5 ng/g fish/day. At the highest dose (400 ng/g fish/day), it reduced body mass (Meador et al., 2011) . In peripubertal and sexually mature mice, at doses (0.5 ng/g) close to the estimated human intake of a high consumer of contaminated fish , TBT increased adipose deposition. At higher doses (50 -500 ng/g) TBT activated tissue-specifically ERs in adipose cells in vitro and in vivo (Penza et al., 2011) . Activation of ER down-regulates LH secretion (Kletter et al., 1997; Wickman et al., 2001) . According to this first interpretation, it might also partly explain the hormonal correlations of TBT to LH in the Finnish samples.
Secondly, if significantly different sources of OTCs exist in Denmark, it is possible that OTCs act as a proxy for other chemical compounds that were not measured in this study. For example, dialkyltins are used as heat and light stabilizers (Hoch, 2001 ) and phthalates are used as softeners in ubiquitous PVC plastics. Although our previous study with the same cohort showed no association between phthalate monoesters levels in breast milk and cryptorchidism, OTC levels in Danish placentas in this study and some phthalate monoesters in mother's milk showed similar types of associations with reproductive hormones levels in 3 months old boys. For phthalates, the most consistent findings were that higher phthalate monoester concentrations in mothers' breast milk were linked to higher serum SHBG levels and LH:free testosterone ratios. For monobutyl phthalates, higher exposure was also associated with lower free serum testosterone levels (Main et al., 2006a) . Regarding OTCs in Danish placentas, higher TBT and/or sum of OTC concentrations tended to be associated with lower serum testosterone and also with lower ratios of testosterone with LH and estradiol.
For OTCs in Finnish placentas, higher TBT and sum OTC concentrations were consistently associated with lower serum LH and higher inhibin B levels. This may indicate that with increasing TBT concentration Leydig cells required less LH drive to produce testosterone, which is a typical androgenic outcome . The positive association of TBT with inhibin B levels is in line with this interpretation since inhibin B levels correlate with testis size and reflect Sertoli cell function (Main et al., 2006b ). In our separate study with the same cohort, serum levels of inhibin B were lower and LH levels were higher in Finnish cryptorchoid boys than in controls, which is also in line with the TBT results of the present study (Suomi et al., 2006) .
Regarding the hormone analysis of this study, even though some of the infants for which placenta OTC measurement were performed were missed for the hormone analyses, very similar proportions of both cases and controls were missed and this will thus not bias the analysis. On average 37% of the Danish cases and 33% of the control infants were missed (i.e. blood sampling did not succeed with the first or second attempt or parents refused to give permission) for hormone analysis, as were 18% of the Finnish case and 24% of the control infants, respectively. Generally, there was little variation among these percentages (+1%) between different hormones or their ratios. However, because estradiol concentrations was non-detectable in some samples where other hormones were successfully measured, for 41% of Danish cases and 33% of Danish controls, and for 46% of Finnish cases and 48% of Finnish controls, it was not possible to calculate the testosterone/estradiol ratio.
The inverse association of TBT in Finnish placentas with cryptorchidism may reflect a true biological effect of TBT. TBT may augment the androgen dependent descent of the testis in the second phase of testicular descent, but the possible mechanism is yet unclear. Given the low concentration of TBT observed in this study such effects would be likely to be mediated by receptors, such as human RXRa to which TBT binds with high affinity (Kanayama et al., 2005) . In female gastropod Nucella lapillus, TBT-exposure down-regulated the transcription of the RXR gene in the central nervous system and up-regulated it in penis of females representing advanced stages of imposex. Also male penis lengths from the TBT-exposed groups were significantly increased at the end of the experiment in comparison with the control group, although no significant difference in RXR gene transcription in penis was observed in males. It was suggested that the central nervous system may control the induction of penis, but TBT may act also as a local morphogen (Lima et al., 2011) . However, the relevance of these observations for humans is unknown.
This study has some obvious weaknesses. The number of cases and controls in both countries was relatively limited and a risk of chance findings always exists with such small numbers. Also the large number of samples ,LOQ especially in Danish placentas decreases the reliability of the study findings and it was necessary to perform largely classified statistical analysis with OTCs.
In conclusion, we found significantly higher levels of DBT and TBT in the placentas of Finnish compared with Danish mothers. Concentrations and TBT/DBT concentration ratios in Danish and Finnish placentas suggest that the most important exposure sources differ between the countries. The associations between OTC levels and cryptorchidism or reproductive hormones, respectively, were country-specific. OTCs appeared to be a risk factor for cryptorchidism and lower androgen levels in Denmark, whereas the opposite was found in Finland.
This observation may be caused by opposite biological effects at low and high body burden of OTCs, the difference in OTC patterns, by unknown compounds for which OTCs act as proxy, or by a yet unknown difference in genetic susceptibility.
